Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00298)
| DIG Name |
Calcium phosphate
|
||||
|---|---|---|---|---|---|
| Synonyms |
Calcium phosphate; 7758-87-4; TRICALCIUM PHOSPHATE; Synthos; Calcium phosphate tribasic; Calcium orthophosphate; Tricalcium diphosphate; Calcigenol simple; beta-TCP; Phosphoric acid, calcium salt (2:3); Tricalcium orthophosphate; beta-Tricalcium phosphate; Calcium tertiary phosphate; Tertiary calcium phosphate; tri-calcium phosphate; FEMA No. 3081; Calciresorb;TCP; 10103-46-5; Phosphoric acid, calcium salt; UNII-K4C08XP666; tricalcium;diphosphate; tricalcium bis(phosphate); CHEBI:9679; K4C08XP666; Synthograft; Bonarka; Cerasorb; OSferion; beta-tri-Calcium phosphate; Natural whitlockite; Calcium Phosphate Nanoparticles; Calcium phosphate, 96%, pure; Caswell No. 148; Ceredex; Multifos; Ostram; Vitoss; TricOs; Calipharm T; Tricafos P; Calcium phosphate (3:2); Tricalcium bis(orthophosphate); CCRIS 3668; HSDB 879; JAX TCP; Calcium phosphate (Ca3(PO4)2); Calcium phosphate, for analysis, 35-40% (Ca); Calcium orthophosphate, tri-(tert); Tricalcium phosphate (Ca3(PO4)2); EINECS 231-840-8; EPA Pesticide Chemical Code 076401; Posture (calcium supplement); bone phosphate; Phosphoric acid calcium(2+) salt (2:3); Ca3(PO4)2; Bone ash; calcium-phosphate; alpha-TCP; Calcium phosphates; tricalciumphosphate; EINECS 233-283-6; Posture (TN); Hydroxyapatite Powder; MFCD00015984; Phosphoric acid, calcium salt (1:?); calcium phosphate basic; beta tricalcium phosphate; AI3-25607; alpha-Tricalcium phosphate; Ca3O8P2; alpha-tri-Calcium phosphate; EC 231-840-8; Calcium Phosphate Nanopowder; BONE POWDER, PURIFIED; INS NO.341(III); INS-341(III); CHEMBL2106566; DTXSID1049803; Calcium phosphate, AR, 96.0%; E-341(III); AKOS015833108; DB11348; Calcium phosphate, 98%,beta-phase basis; S338; Tricalcium bis(orthophosphate), with a fluorine content of less than 0,005 % by weight on the dry anhydrous product; Calcium phosphate, tribasic (ca.37% Ca); CS-0013475; FT-0645103; C08136; D00938; Q278387; UNII-97Z1WI3NDX component QORWJWZARLRLPR-UHFFFAOYSA-H; UNII-279O8I0433 component QORWJWZARLRLPR-UHFFFAOYSA-H; Calcium phosphate, Reagent for transient & stable DNA transfections; beta-tri-Calcium phosphate, >=95% beta-phase basis (unsintered powder); Calcium phosphate, purum p.a., >=96.0% (calc. as Ca3(PO4)2, KT); Tricalcium phosphate hydrate, nanopowder, <200 nm particle size (BET); alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder); alpha-tri-Calcium phosphate, Reagent for transient & stable DNA transfections; beta-tri-Calcium phosphate, puriss. p.a., >=95% beta-phase basis (sintered powder); beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (sintered Powder); beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (unsintered powder); 21063-37-6
|
||||
| DIG Function |
Anticaking agent; Buffering agent; Desiccant; Diluent
|
||||
| Formula |
Ca3O8P2
|
||||
| Canonical SMILES |
[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2]
|
||||
| InChI |
1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6
|
||||
| InChIKey |
QORWJWZARLRLPR-UHFFFAOYSA-H
|
||||
| Physicochemical Properties | Molecular Weight | 310.2 | Topological Polar Surface Area | 173 | |
| XlogP | N.A. | Complexity | 36.8 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 0 | ||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 8 | ||
Full List of Drug(s) Co-administrated with This DIG